Skip to content

Friday, April 26, 2024

Latest:

Research method finds new use in diagnosis of genetic disorders
How the hand muscles have evolved
Patient’s leg saved by Baylor Medicine surgeon
Understanding the neural dynamics of emotional processing in treatment-resistant depression
Prevent trouble with your tattoo

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

PD-1 receptors

A promising two-punch therapy for Langerhans cell histiocytosis

June 29, 2021 dendritic cells, Langerhans cell histiocytosis, MAPK inhibitor, PD-1 receptors, rare cancer, Research, T-cell exhaustion

A novel combination therapy resulted in a significant decrease of disease burden in an animal model of LCH.

From the Labs Image of the Month:

From the Labs: Human retinal organoid.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951